CP2D

CP2D was reported 15 times

CP2D is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPIDURAL ANAESTHESIA 1 0.0179
1 PROCEDURAL SITE REACTION 1 0.0019
2 CHANGE OF BOWEL HABIT 1 0.0005
3 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
4 RETINAL TEAR 1 0.0004
5 HERPES VIRUS INFECTION 1 0.0002
6 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
7 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
8 WOUND INFECTION 1 0.0001
9 NODULE 1 0.0001
10 MYELODYSPLASTIC SYNDROME 1 0.0001
11 PULMONARY MASS 1 0.0001
12 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
13 BASAL CELL CARCINOMA 1 0.0001
14 ERUCTATION 1 0.0001
15 POOR QUALITY SLEEP 1 0.0000
16 HAEMATEMESIS 1 0.0000
17 ANAPHYLACTIC SHOCK 1 0.0000
18 MUCOSAL INFLAMMATION 1 0.0000
19 CELLULITIS 1 0.0000
20 HAEMATOCHEZIA 1 0.0000
21 ARTHROPATHY 1 0.0000
22 NECK PAIN 1 0.0000
23 PANCYTOPENIA 1 0.0000
24 BLISTER 1 0.0000
25 FLATULENCE 1 0.0000
26 BLOOD PRESSURE DECREASED 1 0.0000
27 MOBILITY DECREASED 1 0.0000
28 UNEVALUABLE EVENT 1 0.0000
29 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
30 GASTROINTESTINAL DISORDER 1 0.0000
31 ADVERSE DRUG REACTION 1 0.0000
32 CARDIAC DISORDER 1 0.0000
33 PULMONARY EMBOLISM 1 0.0000
34 RHEUMATOID ARTHRITIS 1 0.0000
35 DISEASE PROGRESSION 1 0.0000
36 JOINT SWELLING 1 0.0000
37 OEDEMA PERIPHERAL 1 0.0000
38 LOSS OF CONSCIOUSNESS 1 0.0000
39 VISION BLURRED 1 0.0000
40 BLOOD PRESSURE INCREASED 1 0.0000
41 HOSPITALISATION 1 0.0000
42 TREMOR 1 0.0000
43 URTICARIA 1 0.0000
44 URINARY TRACT INFECTION 1 0.0000
45 COVID-19 1 0.0000
46 NO ADVERSE EVENT 1 0.0000
47 ANAEMIA 1 0.0000
48 FATIGUE 4 0.0000
49 WEIGHT INCREASED 1 0.0000
50 DEPRESSION 1 0.0000
51 DECREASED APPETITE 1 0.0000
52 BACK PAIN 1 0.0000
53 FEELING ABNORMAL 1 0.0000
54 WEIGHT DECREASED 1 0.0000
55 DYSPNOEA 2 0.0000
56 OFF LABEL USE 3 0.0000
57 CONDITION AGGRAVATED 1 0.0000
58 PAIN 2 0.0000
59 ASTHENIA 1 0.0000
60 ARTHRALGIA 1 0.0000
61 HEADACHE 1 0.0000
62 DIARRHOEA 1 0.0000
63 DRUG INEFFECTIVE 1 0.0000